Humanized IgG1κ monoclonal antibody against PD‐L1 expressed on tumour and non‐tumour cells; inhibits the binding of PD‐L1 to PD‐1 predominantly expressed on T‐cells and thereby blocking a major immunosuppressive pathway. This evidence concerns the gene CD274 and neoplasm.